Recently, in the Adolescent Type 1 Diabetes Cardio‐Renal Intervention Trial (AdDIT) it was investigated whether treatment with angiotensin‐converting enzyme inhibitors and statins may protect against nephropathy [34]. Here, ACE is linked to kidney disorder.